Alzamend Neuro

+$0.0298 (+3.27%) Today
-$0.0008 (-0.08%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Alzamend Neuro and other ETFs, options, and stocks.

About ALZN

Alzamend Neuro, Inc. is a preclinical stage biopharmaceutical company, which engages in the manufacture of pharmaceutical products. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders.

CEO
Stephan Jackman
Employees
2
Headquarters
Tampa, Florida
Founded
2016

ALZN Key Statistics

Market cap
85.05M
Price-Earnings ratio
—
Dividend yield
—
Average volume
415.53K
High today
$1.02
Low today
$0.92
Open price
$0.945
Volume
642.29K
52 Week high
$33.55
52 Week low
$0.8005

ALZN Earnings

-$0.04
-$0.03
-$0.01
$0.00
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
— per share
Actual
Expected Jun 7, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure